Adénocarcinome endométrioïde résultant de foyers d’adénomyose: À propos d’un cas et revue de la littérature

[1]  R. Kurman,et al.  CD10 Immunostaining Does Not Distinguish Endometrial Carcinoma Invading Myometrium From Carcinoma Involving Adenomyosis , 2003, The American journal of surgical pathology.

[2]  T. Kaku,et al.  Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report. , 2002, Gynecologic oncology.

[3]  K. Jones,et al.  Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon. , 2002, Gynecologic oncology.

[4]  K. Fujita,et al.  Adenocarcinomas arising from uterine adenomyosis: a report of four cases. , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  C. Cohen,et al.  Comparative immunohistochemical studies of bcl‐2 and p53 proteins in benign and malignant ovarian endometriotic cysts , 2002, Cancer.

[6]  K. Shiromizu,et al.  Endometrial cytology in early diagnosis of adenocarcinoma arising from adenomyosis uteri. , 2002, Acta cytologica.

[7]  S. Bulun,et al.  Role of aromatase in endometrial disease , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  Y. Ichikawa,et al.  Endometrial carcinoma coexisting with pregnancy, presumed to derive from adenomyosis: a case report. , 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[9]  K. Leslie,et al.  Endometriosis-associated invasive adenocarcinoma involving the rectum in a postmenopausal female , 2001, Diseases of the colon and rectum.

[10]  M. Takahashi,et al.  Endometrioid adenocarcinoma arising from adenomyosis: Report and immunohistochemical analysis of an unusual case , 2001, Pathology international.

[11]  N. Yu.  Dosage of buserelin. , 2000, The Journal of reproductive medicine.

[12]  M. J. Webb,et al.  Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. , 2000, Gynecologic oncology.

[13]  S. Zhang,et al.  [The efficacy and safety of domestic luteinizing hormone-releasing hormone analogue and low-dose norethindrone "add-back" therapy in the treatment of endometriosis]. , 2000, Zhonghua fu chan ke za zhi.

[14]  W. McCluggage,et al.  Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[15]  M. Robbins,et al.  Metastatic carcinoid diagnosed at laparoscopic excision of pelvic endometriosis. , 2000, The Journal of the American Association of Gynecologic Laparoscopists.

[16]  Y. Hayashi,et al.  Prognostic factors relating to survival in uterine endometrioid carcinoma , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  N. Takai,et al.  Endometrioid Adenocarcinoma Arising from Adenomyosis , 1999, Gynecologic and Obstetric Investigation.

[18]  S. Rubin,et al.  Endometrial carcinoma associated with pregnancy: A report of three cases and review of the literature. , 1999, Gynecologic oncology.

[19]  P. Athanassiadou,et al.  Prognostic Significance of p53, bcl-2 and EGFR in Carcinoma of the Endometrium , 1999, Acta Cytologica.

[20]  F. Kung,et al.  Effects of short-course buserelin therapy on adenomyosis. A report of two cases. , 1999, The Journal of reproductive medicine.

[21]  C. la Vecchia,et al.  Role of reproductive factors on the risk of endometrial cancer , 1998, International journal of cancer.

[22]  T. Iwasaka,et al.  Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. , 1998, Gynecologic oncology.

[23]  J. Kodama,et al.  Advanced endometrial cancer detected at 7 months after childbirth. , 1997, Gynecologic oncology.

[24]  M. Shevchuk,et al.  P53 expression in adenomyosis in endometrial carcinoma patients. , 1996, Gynecologic oncology.

[25]  H. Uozaki,et al.  Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[26]  Ivar Heuch,et al.  Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 norwegian women , 1995, International journal of cancer.

[27]  Maguire Pj,et al.  Endometrioid carcinoma arising in endometriosis after 21 years: a case report. , 1991 .

[28]  P. Schwartz,et al.  Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. , 1990, American journal of clinical pathology.

[29]  J. Heaps,et al.  Malignant neoplasms arising in endometriosis , 1990, Obstetrics and gynecology.

[30]  R. Genadry,et al.  Adenocarcinoma arising in adenomyosis detected by atypical cytology. , 1986, Obstetrics and gynecology.

[31]  H. Safaii,et al.  Malignant transformation of vaginal endometriosis. , 1984, Obstetrics and gynecology.

[32]  I. Ariel.  Five-year cure of a primary malignant melanoma of the vagina by local radioactive isotope therapy. , 1961, American journal of obstetrics and gynecology.

[33]  C. C. Marcus.  Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. , 1961, American journal of obstetrics and gynecology.

[34]  J. Sampson.  ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN , 1925 .